Evidence map›Paper›PMID 31815150›Full record

ArticleJournal of immunology research2019

The Intracellular Growth of

Martha Torres, María Teresa Herrera, Guadalupe Fabián-San-Miguel, Yolanda Gonzalez

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of immunology research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Martha TorresSubdirección de Investigación Biomédica, National Institute of Respiratory Diseases, Mexico City, Mexico.
María Teresa HerreraDepartment for Microbiology Research, National Institute of Respiratory Diseases, Mexico City, Mexico.
Guadalupe Fabián-San-MiguelClinic for Metabolic Syndrome, National Institute of Respiratory Diseases, Mexico City, Mexico.
Yolanda GonzalezDepartment for Microbiology Research, National Institute of Respiratory Diseases, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-7066-6188
National Institute of Cardiovascular Diseases · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus, a metabolic disease characterized by hyperglycemia and poor glucose control, is a risk factor for

Indexed as

AdultAgedCase-Control StudiesCell SurvivalDiabetes Mellitus, Type 2FemaleGene ExpressionGlucoseHumansHyperglycemiaInterleukin-10Interleukin-1betaInterleukin-6Interleukin-8Lipopolysaccharide ReceptorsLipopolysaccharidesCD14 protein, humanGlucoseIL10 protein, humanIL1B protein, humanIL6 protein, humanInterleukin-10Interleukin-1betaInterleukin-6Interleukin-8Lipopolysaccharide ReceptorsLipopolysaccharidesLipoproteinsN-palmitoyl-S-(2,3-bis(palmitoyloxy)propyl)cysteinyl-seryl-lysyl-lysyl-lysyl-lysineTLR2 protein, humanTLR4 protein, humanToll-Like Receptor 2Toll-Like Receptor 4Tumor Necrosis Factor-alpha

Identifiers

PMID31815150
PMCPMC6877949
OpenAlexW2985891896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.